Exchange: NASDAQ·Updated 06:44 PM EDT
SLXN logo

SLXN Silexion Therapeutics Ltd

$0.3692
$0.0069
(1.90%)
Today
Closed $0.3697
$0.0005
(0.14%)
After Hours
Reported EarningsAug 14
Mkt Cap$2.09M
Vol154,361.00

About SLXN

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
44

Bearish Sentiment

How do you feel about SLXN?

Advertisement|Remove ads.